USPTO Examiner PAULSON SHEETAL R - Art Unit 3615

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18670458SYSTEM AND METHOD FOR USING A BLOCKCHAIN TO MANAGE MEDICAL TRANSACTIONS BETWEEN ENTITIES IN A HEALTHCARE ECOSYSTEMMay 2024March 2026Abandon2110NoNo
18630687SYSTEMS AND METHODS FOR SCIENTIFIC EVALUATION OF PROGRAM CODE OUTPUTSApril 2024March 2026Abandon2320NoNo
18402599COLLECTION OF DIGITAL HEALTH HUBS WITH ARTIFICIAL INTELLIGENCEJanuary 2024March 2025Allow1410NoNo
18541908Tracking Use of Medical DeviceDecember 2023March 2026Allow2710NoNo
18515154CONTEXT-AWARE HEALTHCARE NOTIFICATION SYSTEMNovember 2023February 2026Allow2710YesNo
18271154PSYCHOLOGICAL TEST SYSTEM AND METHOD USING OPEN PSYCHOLOGICAL SCALE EXPERT PLATFORMJuly 2023March 2026Abandon3220YesNo
18009078ARTIFICIAL INTELLIGENCE FOR SOUND DETECTION FROM MEDICAMENT OR TEST DEVICEMay 2023March 2026Allow3920YesNo
17724156TELEHEALTH SERVICE DELIVERY SYSTEMApril 2022September 2025Abandon4130YesNo
17395612Method and System for Using Artificial Intelligence to Onboard a User for an Exercise PlanAugust 2021February 2026Allow5560YesYes
16380425METHODS AND SYSTEMS OF EMBODIMENT TRAINING IN A VIRTUAL-REALITY ENVIRONMENTApril 2019September 2024Abandon6070YesNo
13620045MEDICAL INFORMATION HANDLING METHODSeptember 2012October 2013Allow1320NoNo
13611309TREATMENT REGIMEN COMPLIANCE AND EFFICACY WITH FEEDBACKSeptember 2012August 2013Allow1110NoNo
13426937METHOD FOR MEASURING HEALTH CARE QUALITYMarch 2012December 2012Allow910NoNo
13403693SYSTEM AND METHOD FOR ESTIMATION OF MISSING DATA IN A MULTIVARIATE LONGITUDINAL SETUPFebruary 2012March 2014Allow2510NoNo
13332687METHOD AND SYSTEM FOR ADJUDICATING CLAIMS IN A HEALTH SERVICES ENVIRONMENTDecember 2011July 2012Allow700NoNo
13324479MEDICAL SUPPORT SYSTEMDecember 2011June 2012Allow600NoNo
13226063TREATMENT REGIMEN COMPLIANCE AND EFFICACY WITH FEEDBACKSeptember 2011June 2012Allow900NoNo
13151527MULTI-USER REMOTE HEALTH MONITORING SYSTEM WITH BIOMETRICS SUPPORTJune 2011April 2013Allow2320NoNo
13027802PATIENT COMMUNICATION METHOD AND SYSTEMFebruary 2011September 2013Allow3130YesNo
13009372Medical Information Handling System and MethodJanuary 2011April 2013Allow2621NoNo
13009458SYSTEM AND METHOD FOR IDENTIFYING AND ASSESSING COMPARATIVE NEGLIGENCE IN INSURANCE CLAIMSJanuary 2011January 2014Allow3630NoNo
12820916MEDICAL SUPPORT SYSTEMJune 2010August 2011Allow1410NoNo
12809007WIDEBAND BIO-IMAGING SYSTEM AND RELATED METHODSJune 2010June 2015Allow6041YesYes
12601587METHOD OF FLUORESCENCE IMAGINGJune 2010July 2015Allow6050YesNo
12675528SYSTEM FOR CONTROLLING THE RELEASE OF AN AUTOMATIC PARKING BRAKE DEVICE ONBOARD AN AUTOMOBILEMay 2010January 2016Allow6050YesYes
12774146System and Method for Coronary Digital Subtraction AngiographyMay 2010September 2016Allow6020NoYes
12767093MULTIPLE PATIENT MONITORING SYSTEM FOR PROACTIVE HEALTH MANAGEMENTApril 2010September 2010Allow400NoNo
12799177SYSTEM AND METHOD FOR CREATING AND USING INTELLIGENT DATABASES FOR ASSISTING IN INTIMA-MEDIA THICKNESS (IMT) MEASUREMENTSApril 2010May 2014Allow4920NoNo
12596629SYSTEM AND METHOD FOR USING THREE DIMENSIONAL INFRARED IMAGING TO PROVIDE DETAILED ANATOMICAL STRUCTURE MAPSMarch 2010September 2012Allow3500NoNo
12725679METHOD AND SYSTEM FOR AUTOMATIC AORTA SEGMENTATIONMarch 2010June 2017Allow6020NoYes
12714720TREATMENT REGIMEN COMPLIANCE AND EFFICACY WITH FEEDBACKMarch 2010June 2011Allow1620NoNo
12627136PATIENT COMMUNICATION METHOD AND SYSTEMNovember 2009October 2010Allow1000NoNo
12556929METHOD AND SYSTEM FOR ELASTIC COMPOSITION OF MEDICAL IMAGING VOLUMESSeptember 2009February 2013Allow4110NoNo
12484835MEDICAL SUPPORT SYSTEMJune 2009March 2010Allow910NoNo
12317901MULTIPLE PATIENT MONITORING SYSTEM FOR PROACTIVE HEALTH MANAGEMENTDecember 2008April 2010Allow1620NoNo
12209879CREATION OF GIS TOOLS AND SPATIAL DATABASE FOR LIMITED ACCESS HIGHWAY ENTRANCE POINTS IN THE US AND CANADASeptember 2008October 2013Allow6030NoNo
12054074OPTIMIZING PHARMACEUTICAL TREATMENT PLANS ACROSS MULTIPLE DIMENSIONSMarch 2008October 2011Allow4210NoNo
11930778DISEASE MANAGEMENT SYSTEM AND HEALTH ASSESSMENT METHODOctober 2007September 2013Allow6070YesNo
11928773MEDICAL INFORMATION SEARCHING AND INDEXING METHOD AND SYSTEMOctober 2007May 2011Allow4350YesNo
11928581MEDICAL BILLING AUDITING METHOD AND SYSTEMOctober 2007June 2011Allow4450YesNo
11923154BLOOD GLUCOSE MONITORING SYSTEMOctober 2007December 2010Allow3710YesNo
11845317TREATMENT REGIMEN COMPLIANCE AND EFFICACY WITH FEEDBACKAugust 2007June 2011Allow4640NoYes
11843727MULTIPLE PATIENT MONITORING SYSTEM FOR PROACTIVE HEALTH MANAGEMENTAugust 2007April 2010Allow3220NoNo
11780774PATIENT COMMUNICATION METHOD AND SYSTEMJuly 2007April 2010Allow3320NoNo
11779664SYSTEM FOR MAINTAINING PERSON'S MEDICAL HISTORY IN PORTABLE MEMORY DEVICEJuly 2007February 2012Allow5540NoNo
11779645MAINTAINING PERSON'S MEDICAL HISTORY IN SELF-CONTAINED PORTABLE MEMORY DEVICEJuly 2007February 2012Allow5540NoNo
11748113BLOOD GLUCOSE MONITORING SYSTEMMay 2007December 2010Allow4300NoNo
11747979BLOOD GLUCOSE MONITORING SYSTEMMay 2007November 2010Allow4310YesNo
11738099FULLY AUTOMATED HEALTH PLAN ADMINISTRATORApril 2007December 2011Allow5611NoNo
11725491METHOD AND SYSTEM FOR TRACKING TREATMENT OF PATIENTS IN A HEALTH SERVICES ENVIRONMENTMarch 2007November 2011Allow5550NoYes
11712376DEVICE FOR FACILITATING COMPLIANCE WITH MEDICATION REGIMENFebruary 2007December 2010Allow4520YesNo
11645439NETWORK MEDIA ACCESS CONTROL SYSTEM FOR ENCOURAGING PATIENT COMPLIANCE WITH A TREATMENT PLANDecember 2006March 2010Allow3920NoNo
11525352NETWORK MEDIA ACCESS CONTROL SYSTEM FOR ENCOURAGING PATIENT COMPLIANCE WITH A TREATMENT PLANSeptember 2006June 2009Allow3330YesNo
11525307NETWORK MEDIA ACCESS CONTROL SYSTEM FOR ENCOURAGING PATIENT COMPLIANCE WITH A TREATMENT PLANSeptember 2006July 2009Allow3420NoNo
11525317NETWORK MEDIA ACCESS CONTROL SYSTEM FOR ENCOURAGING PATIENT COMPLIANCE WITH A TREATMENT PLANSeptember 2006October 2008Abandon2430YesNo
11484211MULTIPLE PATIENT MONITORING SYSTEM FOR PROACTIVE HEALTH MANAGEMENTJuly 2006March 2010Allow4520NoNo
11449724METHOD AND SYSTEM FOR ACQUIRING CLAIMS IN A HEALTH SERVICES ENVIRONMENTJune 2006November 2011Allow6050NoYes
11449722METHOD AND SYSTEM FOR ADJUDICATING CLAIMS IN A HEALTH SERVICE ENVIRONMENTJune 2006November 2011Allow6050YesYes
11412836METHOD AND SYSTEM FOR SCHEDULING TRACKING, ADJUDICATING APPOINTMENTS AND CLAIMS IN A HEALTH SERVICES ENVIRONMENTApril 2006November 2011Allow6020NoNo
11226671BIOLOGICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL CANCERSeptember 2005October 2006Allow1410YesNo
11168525REMOTE HEALTH MONITORING AND MAINTENANCE SYSTEMJune 2005December 2010Allow6070YesYes
10938503Attached personal information deviceSeptember 2004September 2016Allow6080NoYes
10863678METHOD TO IMPROVE HOSPITAL REVENUESJune 2004October 2009Allow6020YesNo
10863791METHOD TO PROVIDE EMERGENCY HEALTH CARE TO PATIENTS WITH INSURANCEJune 2004December 2009Allow6010YesNo
10826107REMOTE HEALTH MONITORING AND MAINTENANCE SYSTEMApril 2004August 2010Allow6040NoYes
10780098METHOD, SYSTEM, AND APPARATUS FOR PATIENT CONTROLLED ACCESS OF MEDICAL RECORDSFebruary 2004January 2012Allow6060NoYes
10605900METHOD AND APPARATUS FOR PROVIDING ACCESS TO HEALTHCARE FUNDSNovember 2003July 2013Allow6070NoYes
10674929SYSTEM OF CHARGING FOR AUTOMOBILE INSURANCESeptember 2003February 2009Allow6020YesYes
10608265METHOD FOR CONDUCTING PRESCRIPTION DRUG CO-PAYMENT PLANSJune 2003September 2009Allow6040NoNo
10438327SYSTEM AND METHOD FOR HANDLING MEDICAL INFORMATIONMay 2003October 2010Allow6051YesNo
10349079EXAMINATION RESERVE SYSTEM, MAINTENANCE SERVICE SYSTEM, MEDICAL IMAGING APPARATUS, EXAMINATION RESERVE METHOD, AND MAINTENANCE SERVICE METHODJanuary 2003June 2011Allow6030YesNo
10331034MEDICATION MANAGEMENT SYSTEMDecember 2002July 2010Allow6021NoYes
10319297METHOD AND APPARATUS FOR PROVIDING ACCESS TO HEALTHCARE FUNDSDecember 2002March 2012Allow6050NoYes
10279749Public health surveillance systemOctober 2002September 2013Allow6050YesYes
10272673METHOD AND APPARATUS FOR INSURANCE RISK MANAGEMENTOctober 2002December 2008Allow6011NoNo
10233296MULTI-USER REMOTE HEALTH MONITORING SYSTEM WITH BIOMETRICS SUPPORTAugust 2002February 2011Allow6061NoNo
10214868SYSTEM AND METHOD FOR IDENTIFYING AND ASSESSING COMPARATIVE NEGLIGENCE IN INSURANCE CLAIMSAugust 2002September 2010Allow6050NoYes
10017652MEDICAL SUPPORT SYSTEMDecember 2001May 2007Abandon6050NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAULSON, SHEETAL R..

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
1
(12.5%)
Examiner Reversed
7
(87.5%)
Reversal Percentile
91.0%
Higher than average

What This Means

With a 87.5% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
26
Allowed After Appeal Filing
12
(46.2%)
Not Allowed After Appeal Filing
14
(53.8%)
Filing Benefit Percentile
75.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 46.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner PAULSON, SHEETAL R. - Prosecution Strategy Guide

Executive Summary

Examiner PAULSON, SHEETAL R. works in Art Unit 3615 and has examined 70 patent applications in our dataset. With an allowance rate of 95.7%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 49 months.

Allowance Patterns

Examiner PAULSON, SHEETAL R.'s allowance rate of 95.7% places them in the 85% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PAULSON, SHEETAL R. receive 2.93 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PAULSON, SHEETAL R. is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -6.6% benefit to allowance rate for applications examined by PAULSON, SHEETAL R.. This interview benefit is in the 4% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.2% of applications are subsequently allowed. This success rate is in the 28% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 35.9% of cases where such amendments are filed. This entry rate is in the 54% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 37% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 70.4% of appeals filed. This is in the 57% percentile among all examiners. Of these withdrawals, 31.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 35.0% are granted (fully or in part). This grant rate is in the 23% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 21.4% of allowed cases (in the 98% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 35% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.